VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.
VRG Therapeutics has raised $5.5M in total funding. The most recent round was Series A. The last funding was announced in August 2023.
VRG Therapeutics's investors include Széchenyi Capital Fund Management, The Vascular Group.
VRG Therapeutics is headquartered in Budapest, Hungary.
VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.
VRG Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VRG Therapeutics — Funding & Investors." VCBacked, August 14, 2023, https://www.vcbacked.co/company/vrg-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). VRG Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vrg-therapeutics
{{cite web |title=VRG Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vrg-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated